Christopher C. Caillouet

Array ( [id] => 5136508 [patent_doc_number] => 20070078137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Method of inhibiting neurotrophin-receptor binding' [patent_app_type] => utility [patent_app_number] => 11/525841 [patent_app_country] => US [patent_app_date] => 2006-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16315 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20070078137.pdf [firstpage_image] =>[orig_patent_app_number] => 11525841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740616 [patent_doc_number] => 20080234269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'N-Oxo-Heterocycle and N-Oxo-Alkyl Quinoline-4-Carboxamides as Nk-3 Receptor Ligands' [patent_app_type] => utility [patent_app_number] => 12/067559 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6673 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234269.pdf [firstpage_image] =>[orig_patent_app_number] => 12067559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4451409 [patent_doc_number] => 07964733 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'Alkyl sulfoxide quinolines as NK-3 receptor ligands' [patent_app_type] => utility [patent_app_number] => 12/067572 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10772 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964733.pdf [firstpage_image] =>[orig_patent_app_number] => 12067572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4639748 [patent_doc_number] => 08017775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-13 [patent_title] => '1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity' [patent_app_type] => utility [patent_app_number] => 11/992088 [patent_app_country] => US [patent_app_date] => 2006-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 102901 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/017/08017775.pdf [firstpage_image] =>[orig_patent_app_number] => 11992088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92613 [patent_doc_number] => 07732613 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Met kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/520520 [patent_app_country] => US [patent_app_date] => 2006-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12679 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732613.pdf [firstpage_image] =>[orig_patent_app_number] => 11520520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496398 [patent_doc_number] => 20090264426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Bicyclic aromatic substituted pyridone derivative' [patent_app_type] => utility [patent_app_number] => 11/991334 [patent_app_country] => US [patent_app_date] => 2006-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47038 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264426.pdf [firstpage_image] =>[orig_patent_app_number] => 11991334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6356038 [patent_doc_number] => 20100022531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'NOVEL COMPOUNDS AS P2X7 MODULATORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/991485 [patent_app_country] => US [patent_app_date] => 2006-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35873 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022531.pdf [firstpage_image] =>[orig_patent_app_number] => 11991485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5689081 [patent_doc_number] => 20060287396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => '4-aryl quinols and analogs thereof as therapeutic agents' [patent_app_type] => utility [patent_app_number] => 11/511369 [patent_app_country] => US [patent_app_date] => 2006-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 39137 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287396.pdf [firstpage_image] =>[orig_patent_app_number] => 11511369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765744 [patent_doc_number] => 20080176956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Modified Green Tea Polyphenol Formulations' [patent_app_type] => utility [patent_app_number] => 12/063139 [patent_app_country] => US [patent_app_date] => 2006-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9458 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176956.pdf [firstpage_image] =>[orig_patent_app_number] => 12063139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840463 [patent_doc_number] => 20080280949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Oxopyridyl Quinoline Amides as Nk3 Receptor Modulators' [patent_app_type] => utility [patent_app_number] => 12/063136 [patent_app_country] => US [patent_app_date] => 2006-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6086 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280949.pdf [firstpage_image] =>[orig_patent_app_number] => 12063136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4813992 [patent_doc_number] => 20080194623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Method for the Synthesis of Quinoline Derivatives' [patent_app_type] => utility [patent_app_number] => 11/997378 [patent_app_country] => US [patent_app_date] => 2006-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7980 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20080194623.pdf [firstpage_image] =>[orig_patent_app_number] => 11997378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205702 [patent_doc_number] => 20070027184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease' [patent_app_type] => utility [patent_app_number] => 11/496784 [patent_app_country] => US [patent_app_date] => 2006-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20229 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027184.pdf [firstpage_image] =>[orig_patent_app_number] => 11496784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5576067 [patent_doc_number] => 20090143429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Quinoline Derivatives as Neurokinin Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 12/225931 [patent_app_country] => US [patent_app_date] => 2006-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11439 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143429.pdf [firstpage_image] =>[orig_patent_app_number] => 12225931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172376 [patent_doc_number] => 20070072809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Antiviral compounds' [patent_app_type] => utility [patent_app_number] => 11/487542 [patent_app_country] => US [patent_app_date] => 2006-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41008 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072809.pdf [firstpage_image] =>[orig_patent_app_number] => 11487542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4985 [patent_doc_number] => 07812168 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'Purification of montelukast' [patent_app_type] => utility [patent_app_number] => 11/481877 [patent_app_country] => US [patent_app_date] => 2006-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7904 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/812/07812168.pdf [firstpage_image] =>[orig_patent_app_number] => 11481877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7693868 [patent_doc_number] => 20070015818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Cyclic sulfone containing retroviral protease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/480586 [patent_app_country] => US [patent_app_date] => 2006-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15280 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015818.pdf [firstpage_image] =>[orig_patent_app_number] => 11480586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629417 [patent_doc_number] => 20100004271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'HETEROCYCLIC COMPOUNDS AS AGANIST FOR THE THYROID RECEPTOR' [patent_app_type] => utility [patent_app_number] => 11/922554 [patent_app_country] => US [patent_app_date] => 2006-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29187 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004271.pdf [firstpage_image] =>[orig_patent_app_number] => 11922554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386326 [patent_doc_number] => 20090227571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Androgen Receptor Modulator Compounds and Methods' [patent_app_type] => utility [patent_app_number] => 11/921366 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 95593 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227571.pdf [firstpage_image] =>[orig_patent_app_number] => 11921366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5924496 [patent_doc_number] => 20060241138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Heterocyclic amide derivatives for the treatment of diabetes and other diseases' [patent_app_type] => utility [patent_app_number] => 11/476330 [patent_app_country] => US [patent_app_date] => 2006-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 33889 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241138.pdf [firstpage_image] =>[orig_patent_app_number] => 11476330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051977 [patent_doc_number] => 20070032522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Antiviral agents' [patent_app_type] => utility [patent_app_number] => 11/478371 [patent_app_country] => US [patent_app_date] => 2006-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13951 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032522.pdf [firstpage_image] =>[orig_patent_app_number] => 11478371 [rel_patent_id] =>[rel_patent_doc_number] =>)